EvaluatePharma's new World Preview report predicts that the market for anticoagulant drugs will soar by 11.5% annually through 2018, hitting $15.3 billion in sales. (Right now, the market is valued at $8 billion.) The next-fastest-growing therapeutic area is oncology, EvaluatePharma says, at 9% annually.